Showing results (171-180 of 516) with videos related to

Sort By:
Pageof 52
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 28, 2003
Influence of caveolin on constitutively activated recombinant eNOS: insights into eNOS dysfunction in BDL rat liverH Hendrickson, S Chatterjee, S Cao, et al.
Circulation Research|November 14, 1997
17 beta-estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilizationT Caulin-Glaser, G García-Cardeña, P Sarrel, et al.
Cancer Treatment Reviews|August 12, 2018
Clinical benefit of controversial first line systemic therapies for advanced stage ovarian cancer - ESMO-MCBS scoresK E Broekman, M Jalving, H van Tinteren, et al.
The Journal of Physiology|July 15, 1996
Inhibition of nitric oxide synthase does not alter ocular dominance shifts in kitten visual cortexS N Reid, N W Daw, D Czepita, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 1998
Phase I multicenter study of combined high-dose ifosfamide and doxorubicin in the treatment of advanced sarcomas. Swiss Group for Clinical Research (SAKK)S Leyvraz, M Bacchi, T Cerny, et al.
Investigational New Drugs|February 20, 2015
Phase-I dose finding and pharmacokinetic study of the novel hydrophilic camptothecin ST-1968 (namitecan) in patients with solid tumorsM Joerger, D Hess, A Delmonte, et al.
Biochemical and Biophysical Research Communications|October 15, 1990
L-glutamine inhibits the release of endothelium-derived relaxing factor from the rabbit aortaT A Swierkosz, J A Mitchell, W C Sessa, et al.
Cancer Treatment Reports|January 1, 1985
Pharmacokinetics of teniposide in patients with ovarian cancerM D'Incalci, C Rossi, C Sessa, et al.
Plos One|February 25, 2012
Proteomic identification of S-nitrosylated Golgi proteins: new insights into endothelial cell regulation by eNOS-derived NOPanjamaporn Sangwung, Todd M Greco, Yanzhuang Wang, et al.
Bone Marrow Transplantation|July 27, 2004
HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell supportV Guarneri, C Bengala, C Orlandini, et al.
Pageof 52